← Back
$CVKD All transactions

Cadrenal Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$69K

Shares

9,933

Price

$7

Filed

Dec 31

Insider

Name

Szot Matthew K

Title

Chief Financial Officer

CIK

0001401385

Roles

Officer

Transaction Details

Transaction Date

2025-12-29

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 18, 2025, in multiple transactions at prices ranging from $6.83 through $7.37, inclusive, having a weighted average price as shown in column 4 of $6.97. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing Info

Accession No.

0001213900-25-127110

Form Type

4

Issuer CIK

0001937993

Szot Matthew K's History

Date Ticker Type Value
2025-12-29 CVKD $69K
2025-12-04 IVF J $0
2025-12-03 IVF $6
2025-11-14 SNES $3
2025-10-27 CVKD $25K
2025-10-24 CVKD $25K
2025-10-13 CVKD $25K
2025-10-09 CVKD $24K
2025-10-06 CVKD $1K
2025-10-01 CVKD $24K

Other Insiders at CVKD (90d)

No other insider activity at this issuer in the last 90 days.